Characterisation of a G9P[8] rotavirus strain identified during a gastroenteritis outbreak in Alice Springs, Australia post Rotarix™ vaccine introduction

Vaccine

Volumn 30, Issue SUPPL. 1, 2012, Pages

  Donato, C M ^a,b   Cannan, D ^a   Bogdanovic Sakran, N ^a   Snelling, T L ^c   Kirkwood, C D ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Australia; G9P 8 ; Gastroenteritis; Rotarix ; Rotavirus

Indexed keywords

AMINO ACID; PROTEIN VP4; PROTEIN VP7; PROTEIN VP8; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; AUSTRALIA; DRUG EFFICACY; EPIDEMIC; G9P[8] ROTAVIRUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; ROTAVIRUS; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VACCINATION; VIRAL GASTROENTERITIS; VIRUS IDENTIFICATION; VIRUS STRAIN;

ADOLESCENT; ANTIGENS, VIRAL; CAPSID PROTEINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DISEASE OUTBREAKS; FEMALE; GASTROENTERITIS; GENOTYPE; GLYCOPROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MOLECULAR SEQUENCE DATA; NORTHERN TERRITORY; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEQUENCE ANALYSIS, DNA; TOXINS, BIOLOGICAL; VACCINES, ATTENUATED; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84859953371     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.119     Document Type: Article

References (37)

1. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973, 7841:1281-1283.
2. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M-A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368:323-332.
3. Parashar U.D., Gibson C.J., Bresee J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12:304-306.
4. Estes M.K., Kapikian A.Z. Rotaviruses. Fields Virology, 2 2007, 1917-1974. Lippincott, Williams & Wilkins, Philadelphia, PA. 5th ed. D.M.K. Knipe, P.M. Howley, D.E. Griffin, R.A. Lambert, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
5. Gentsch J.R., Laird A.R., Bielfelt B., Griffin D.D., Bányai K., Ramachandran M., et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005, 192(Suppl. 1):S146-S159.
6. Maes P., Matthijnssens J., Rahman M., Van Ranst M. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol 2009, 9:238.
7. Patel M.M., Steele D., Gentsch J.R., Wecker J., Glass R.I., Parashar U.D. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011, 30(Suppl. 1):S1-S5.
8. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005, 15:29-56.
9. Clark H.F., Hoshino Y., Bell L.M., Groff J., Hess G., Bachman P., et al. Rotavirus isolate WI61 representing a presumptive new human serotype. J Clin Microbiol 1987, 25:1757-1762.
10. Nakagomi T., Ohshima A., Akatani K., Ikegami N., Katsushima N., Nakagomi O. Isolation and molecular characterization of a serotype 9 human rotavirus strain. Microbiol Immunol 1990, 34:77-82.
11. Grimwood K., Lambert S.B. Rotavirus vaccines: opportunities and challenges. Hum Vaccines 2009, 5:57-69.
12. Vesikari T., Karvonen A., Prymula R., Schuster V., Tejedor J.C., Cohen R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007, 370:1757-1763.
13. Heaton P.M., Govie M.G., Miller J.M., Offit P., Clark H.F. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J Infect Dis 2005, 192:S17-S21.
14. Macartney K.K., Porwal M., Dalton D., Cripps T., Maldigri T., Isaacs D., et al. Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. J Paediatr Child Health 2011, 47:266-270.
15. Buttery J.P., Lambert S.B., Grimwood K., Nissen M.D., Field E.J., Macartney K.K., et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule. Pediatr Infect Dis J 2011, 30(Suppl. 1):S25-S29.
16. Galati J.C., Harsley S., Richmond P., Carlin J.B. The burden of rotavirus-related illness among young children on the Australian health care system. Aust NZ J Public Health 2006, 30:416-421.
17. Gouvea V., Allen J.R., Glass R.I., Fang Z.Y., Bremont M., Cohen J., et al. Detection of group B and C rotaviruses by polymerase chain reaction. J Clin Microbiol 1991, 29:519-523.
18. Dyall-Smith M.L., Holmes I.H. Sequence homology between human and animal rotavirus serotype-specific glycoproteins. Nucleic Acids Res 1984, 12:3973-3982.
19. Herring A.J., Inglis N.F., Ojeh C.K., Snodgrass D.R., Menzies J.D. Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol 1982, 16:473-477.
20. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990, 28:276-282.
21. Simmonds M.K., Armah G., Asmah R., Banerjee I., Damanka S., Esona M., et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 2008, 42:368-373.
22. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992, 30:1365-1373.
23. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
24. Tamura K., Dudley J., Nei M., Kumar S. MEGA4.Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599.
25. Kirkwood C.D., Cannan D., Bogdanovic-Sakran N., Bishop R.F., Barnes G.L. Australian rotavirus surveilance program: annual report, 2006-07. Commun Dis Intell 2007, 31:375-379.
26. Palombo E.A., Masendycz P.J., Bugg H.C., Bogdanovic-Sakran N., Barnes G.L., Bishop R.F. Emergence of serotype G9 human rotaviruses in Australia. J Clin Microbiol 2000, 38:1305-1306.
27. Kirkwood C.D., Bogdanovic-Sakran N., Clark R., Masendycz P.J., Bishop R.F., Barnes G.L. Report of the Australian rotavirus surveillance program, 2001/2002. Commun Dis Intell 2002, 26:537-540.
28. Kirkwood C.D., Boniface K., Bogdanovic-Sakran N., Masendycz P., Barnes G.L., Bishop R.F. Rotavirus strain surveillance-an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. Vaccine 2009, 27S:F102-F107.
29. Kirkwood C.D., Bogdanovic-Sakran N., Clark R., Bishop R.F., Barnes G.L. National Rotavirus surveillance program annual report, 2005-06. Commun Dis Intell 2006, 30:434-438.
30. Siqueira A.A., Santelli A.C.F.S., Alencar L.R., Dantas M.P., Dimech C.P.N., Carmo G.M.I., et al. Outbreak of acute gastroenteritis in young children with death due to rotavirus genotype G9 in Rio Branco, Brazilian Amazon region, 2005. Int J Infect Dis 2010, 14:e898-e903.
31. Tort L.F.L., Volotão E.d.M., de Mendonça M.C.L., da Silva M.F.M., Siqueira A.A., Assis R.M.S., et al. Phylogenetic analysis of human P[8] G9 rotavirus strains circulating in Brazil reveals the presence of a novel genetic variant. J Clin Virol 2010, 47:345-355.
32. Ball J., Mitchell D.M., Gibbons T.F., Parr R.D. Rotavirus NSP4.A multifunctional viral enterotoxin. Viral Immunol 2005, 18:27-40.
33. Phan T.G., Okitsu S., Maneekarn N., Ushijima H. Genetic heterogeneity, evolution and recombination in emerging G9 rotaviruses. Infect Genet Evol 2007, 7:656-663.
34. Espínola E.E., Amarilla A., Arbiza J., Parra G., Sequence I. phylogenetic analysis of the VP4 gene of human rotaviruses isolated in Paraguay. Arch Virol 2008, 153:1067-1073.
35. Snelling T.L., Schultz R., Graham J., Roseby R., Barnes G.L., Andrews R.M., et al. Rotavirus and the Indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin Infect Dis 2009, 49:428-431.
36. De Vos B., Han H.H., Bouckenooghe A., Debrus S., Gillard P., Ward R., et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009, 28:261-266.
37. Graham J., Cook H., Roberts C., Kirkwood C.D. An estimate of rotavirus vaccine efficacy following an outbreak of rotavirus gastroenteritis in Central Australia. Northern Territory Dis Control Bull 2007, 14:8-13.